Section 1 Short title
This Act may be cited as the “Improving National Safety, Public health, Ethics, and Clinical Trials Act” or the “INSPECT Act”.
Improving National Safety, Public health, Ethics, and Clinical Trials Act
A BILL
To establish an Inspector General of the National Institutes of Health, an Inspector General of the Centers for Disease Control and Prevention, and an Inspector General for the Food and Drug Administration.
Sec. 2 Establishment of Inspectors General of the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administration
in paragraph (1), by striking “or the National Reconnaissance Office,” and inserting “the National Reconnaissance Office, the National Institutes of Health, the Centers for Disease Control and Prevention, or the Food and Drug Administration,”; and
in paragraph (3), by striking “or the Director of the National Reconnaissance Office;” and inserting “the Director of the National Reconnaissance Office; the Director of the National Institutes of Health; the Director for the Centers for Disease Control and Prevention; or the Commissioner of Food and Drugs,”.
Appointment of Inspectors General— Not later than 1 year after the date of enactment of this Act, the President shall, in accordance with section 403(a) of title 5, United States Code—
appoint an individual to serve as the Inspector General of the National Institutes of Health;
appoint an individual to serve as the Inspector General of the Centers for Disease Control and Prevention; and
appoint an individual to serve as the Inspector General of the Food and Drug Administration.
Sec. 3 Compliance with CUTGO
This Act and the amendments made by this Act shall be carried out using amounts otherwise appropriated to the Office of the Inspector General of the Department of Health and Human Services, and no additional amounts are authorized to be appropriated to carry out this Act or the amendments made by this Act.